Skip to content

HealthEquity HQY EBITDA margin

EBITDA margin at other companies

UnitedHealth Group logo
UnitedHealth GroupUNH
5.2%-4.0pp
Webster Financial Corporation logo
Webster Financial CorporationWBS
64.3%+1.1pp
Willis Towers Watson logo
Willis Towers WatsonWTW
27%+14.6pp
CVS Health logo
CVS HealthCVS
2.6%-1.2pp
Centene logo
CenteneCNC
-3%-5.9pp
MetLife logo
MetLifeMET
7%-1.9pp

Other financials

Income statement

See full
Revenue$354.6M+7.2%
Gross profit$256.3M+14.3%
Operating income$103.0M+23.9%
Net income$69.4M+28.8%
EPS (diluted)$0.82+34.4%

Balance sheet

See full
Cash & equivalents$265.4M-7.8%
Total debt$984.7M-11.0%
Total equity$2.0B-3.6%
Total assets$3.3B-3.2%

Cash flow

See full
Operating cash flow$97.5M+50.6%
CapEx$362.0K+321%
Free cash flow$97.2M+50.3%

Valuation

See full
Market cap$7.12B-6.7%
Enterprise value$7.84B-7.2%
P/E30.9×-31.8×
P/S5.3×-0.8×

Profitability

See full
Gross margin70.7%+5.2pp
Operating margin25.6%+9.2pp
Net margin17.3%+7.5pp
FCF margin36.5%+9.3pp

Returns & leverage

See full
Return on equity11.1%+5.3pp
Debt / equity0.5×0.0×
Current ratio3.4×-0.6×

Where this comes from

Calculated from HealthEquity’s reported figures.

Based on trailing twelve months.

The official record: HealthEquity’s 10-Q, filed May 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about HealthEquity's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is HealthEquity's EBITDA margin?
HealthEquity (HQY) reported EBITDA margin of 37.1% in Q1 2026.
How has HealthEquity's EBITDA margin changed year-over-year?
HealthEquity's EBITDA margin increased by 26.1% year-over-year, from 29.4% to 37.1%.
What is the long-term trend for HealthEquity's EBITDA margin?
Over 5 years (2021 to 2026), HealthEquity's EBITDA margin has grown at a 12.0% compound annual growth rate (CAGR), from 20.7% to 36.3%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.